ACCO Brands completes acquisition of GXT Holding B.V.
ACCO Brands Corp has completed its acquisition of GXT Holding B.V., enhancing its position in the computer and gaming accessories market.
Cycurion Announces Record Contract Win and Strategic Acquisition
Cycurion, Inc. reports a record contract win and acquisition to expand its public safety technology, signaling growth in the cybersecurity sector.
Silexion Therapeutics boosts authorized share capital by 500M
Silexion Therapeutics Corp increases authorized share capital by 500 million shares, enhancing its financial flexibility and growth potential.
Integra LifeSciences updates Q3 results, lowers full-year guidance
Integra LifeSciences announces preliminary Q3 results, projecting revenue of $410-$412 million, impacted by flooding at its Cincinnati facility.
Apollo Asset Backed Credit Co Reports Unregistered Equity Sales
Apollo Asset Backed Credit Co LLC announces unregistered sales of equity securities, impacting its strategies and potentially influencing the finance services industry.
Sun Communities reports Q3 2026 results, plans investor call
Sun Communities, Inc. announces its Q3 2026 financial results, showcasing strong performance in the real estate investment trust sector.
Rallybio Corp Declares Special Cash Distribution Amid Merger
Rallybio Corp announces an $82.7 million cash distribution to shareholders in connection with its merger with Avenzo Therapeutics, set for November 2026.
Nucor reports strong Q3 2026 earnings and sales results
Nucor Corp announces robust financial results for Q3 2026, highlighting significant earnings and sales growth amid strong demand in the steel industry.
CNL Strategic Residential Credit Updates Net Asset Value Per Share
CNL Strategic Residential Credit, Inc. updates net asset value per share for Class FA and Class E shares, effective October 30, 2026.
Kinetik Holdings settles NGL purchase agreement dispute
Kinetik Holdings Inc. settles a dispute with Energy Transfer over an NGL purchase agreement, confirming its expiration date as December 31, 2026.
Mirum Pharmaceuticals Reports Positive Results for ATEBRIOZ
Mirum Pharmaceuticals shares positive results from the PROGRESS study for ATEBRIOZ in pediatric patients with fibrodysplasia ossificans progressiva.
Standex International appoints new director, Brenna Preisser
Standex International Corporation announces Brenna D. Preisser as a new board member, succeeding B. Joanne Edwards, effective January 1, 2027.
Soren Acquisition Corp. announces leadership transition
Soren Acquisition Corp. implements leadership changes, appointing new directors and a CFO to enhance governance and operational strategy.
Genvor Inc Signs Key Intellectual Property Agreement
Genvor Inc has entered into an Intellectual Property Assignment Agreement with Dr. Jesse Jaynes, enhancing its R&D capabilities in agricultural production.
Praetorian Acquisition Corp. announces leadership changes
Praetorian Acquisition Corp. undergoes a leadership transition with new directors and a CFO, impacting its governance and the blank check industry.
Churchill Capital Corp XIII appoints Paul Lapping to board
Churchill Capital Corp XIII has appointed Paul Lapping as a director, enhancing its leadership in the blank check industry.
Cumberland Pharmaceuticals to Submit New Drug Application for Ifetroban
Cumberland Pharmaceuticals plans to submit a New Drug Application for ifetroban, targeting cardiomyopathy in Duchenne muscular dystrophy patients.
Bain Capital Private Credit Announces Unregistered Share Sale
Bain Capital Private Credit reports the sale of unregistered Class I common shares, indicating strong investor interest in private credit.
CV Sciences settles arbitration with former legal counsel
CV Sciences, Inc. settles arbitration with former legal counsel for $500,000, enhancing its financial position and focusing on core operations.
Columbus McKinnon Declares Quarterly Dividend of $0.07
Columbus McKinnon Corp announces a quarterly dividend of $0.07 per share, reflecting its commitment to shareholder value and financial stability.